These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 31752941

  • 1. Prognostic and diagnostic validity of p16/Ki-67, HPV E6/E7 mRNA, and HPV DNA in women with ASCUS: a follow-up study.
    Ren C, Zhu Y, Yang L, Zhang X, Liu L, Wang Z, Jiang D.
    Virol J; 2019 Nov 21; 16(1):143. PubMed ID: 31752941
    [Abstract] [Full Text] [Related]

  • 2. Performance of p16/Ki67 immunostaining, HPV E6/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS.
    Zhu Y, Ren C, Yang L, Zhang X, Liu L, Wang Z.
    BMC Cancer; 2019 Mar 27; 19(1):271. PubMed ID: 30917784
    [Abstract] [Full Text] [Related]

  • 3. [The role of HPV E6/E7 mRNA combined with P16/ki67 immunocytochemistry in the diagnosis of atypical squamous cells of undetermined significance(ASCUS)].
    Zhan X, Wang S, Wu X, Qiu X, Li F, Zeng Y, Chen Z.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Oct 27; 34(10):937-941. PubMed ID: 30554588
    [Abstract] [Full Text] [Related]

  • 4. p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women.
    Giorgi Rossi P, Carozzi F, Ronco G, Allia E, Bisanzi S, Gillio-Tos A, De Marco L, Rizzolo R, Gustinucci D, Del Mistro A, Frayle H, Confortini M, Iossa A, Cesarini E, Bulletti S, Passamonti B, Gori S, Toniolo L, Barca A, Bonvicini L, Mancuso P, Venturelli F, Benevolo M, the New Technology for Cervical Cancer 2 Working Group.
    J Natl Cancer Inst; 2021 Mar 01; 113(3):292-300. PubMed ID: 32745170
    [Abstract] [Full Text] [Related]

  • 5. Sensitivity and specificity values of high-risk HPV DNA, p16/ki-67 and HPV mRNA in young women with atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesion (LSIL).
    Frega A, Pavone M, Sesti F, Leone C, Bianchi P, Cozza G, Colombrino C, Lukic A, Marziani R, De Sanctis L, Delli Carpini G, Caserta D, Ciavattini A.
    Eur Rev Med Pharmacol Sci; 2019 Dec 01; 23(24):10672-10677. PubMed ID: 31858534
    [Abstract] [Full Text] [Related]

  • 6. A prospective study of women with ASCUS or LSIL pap smears at baseline and HPV E6/E7 mRNA positive: a 3-year follow-up.
    Bruno MT, Ferrara M, Fava V, Barrasso G, Panella MM.
    Epidemiol Infect; 2018 Apr 01; 146(5):612-618. PubMed ID: 29465024
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic performance of HPV E6/E7 mRNA assay for detection of cervical high-grade intraepithelial neoplasia and cancer among women with ASCUS Papanicolaou smears.
    Ren C, Zhu Y, Yang L, Zhang X, Liu L, Ren C.
    Arch Gynecol Obstet; 2018 Feb 01; 297(2):425-432. PubMed ID: 29143102
    [Abstract] [Full Text] [Related]

  • 8. [Clinical effect evaluation of high risk human papilloma virus E6/E7 mRNA in triaging women with atypical squamous cells of undetermined significance].
    Guo Z, Zhao DM, Zhang SK, Wu ZN, Sun XB, Jia MM, Chen Q, Guo LW, Chen PP, Zhang JG.
    Zhonghua Zhong Liu Za Zhi; 2021 Oct 23; 43(10):1094-1099. PubMed ID: 34695901
    [Abstract] [Full Text] [Related]

  • 9. Performance of p16INK4a/Ki-67 immunocytochemistry for identifying CIN2+ in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion specimens: a Japanese Gynecologic Oncology Group study.
    Fujii T, Saito M, Hasegawa T, Iwata T, Kuramoto H, Kubushiro K, Ohmura M, Ochiai K, Arai H, Sakamoto M, Motoyama T, Aoki D.
    Int J Clin Oncol; 2015 Feb 23; 20(1):134-42. PubMed ID: 24744261
    [Abstract] [Full Text] [Related]

  • 10. The clinical application of HPV E6/E7 mRNA testing in triaging women with atypical squamous cells of undetermined significance or low-grade squamous intra-epithelial lesion Pap smear: A meta-analysis.
    Yang L, Zhu Y, Bai Y, Zhang X, Ren C.
    J Cancer Res Ther; 2017 Feb 23; 13(4):613-620. PubMed ID: 28901302
    [Abstract] [Full Text] [Related]

  • 11. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method.
    Bishop JA, Ma XJ, Wang H, Luo Y, Illei PB, Begum S, Taube JM, Koch WM, Westra WH.
    Am J Surg Pathol; 2012 Dec 23; 36(12):1874-82. PubMed ID: 23060353
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic validity of human papillomavirus E6/E7 mRNA test in cervical cytological samples.
    Liu TY, Xie R, Luo L, Reilly KH, He C, Lin YZ, Chen G, Zheng XW, Zhang LL, Wang HB.
    J Virol Methods; 2014 Feb 23; 196():120-5. PubMed ID: 24216236
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic performance of HPV E6/E7 mRNA testing towards HPV-DNA testing and p16/Ki67 immunostaining as a biomarker of high-risk HPV recurrence in Greek women surgically treated for their cervical lesions.
    Carcea F, Vavoulidis E, Petousis S, Papandreou P, Siarkou CM, Nasioutziki M, Papanikolaou A, Dinas K, Daniilidis A.
    J Obstet Gynaecol Res; 2021 Oct 23; 47(10):3607-3617. PubMed ID: 34374179
    [Abstract] [Full Text] [Related]

  • 14. Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results.
    Reuschenbach M, Clad A, von Knebel Doeberitz C, Wentzensen N, Rahmsdorf J, Schaffrath F, Griesser H, Freudenberg N, von Knebel Doeberitz M.
    Gynecol Oncol; 2010 Oct 23; 119(1):98-105. PubMed ID: 20619445
    [Abstract] [Full Text] [Related]

  • 15. [The value of P16/ki67 double labeling, HPV E6/E7 mRNA detection and their combined application in cytological shunt diagnosis of low-grade squamous intraepithelial lesions].
    Guan Y, Peng J, Yuan C, Mi X, Chen Z, Chen J, Chen A, Liu J.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Jan 23; 36(1):63-68. PubMed ID: 32314725
    [Abstract] [Full Text] [Related]

  • 16. Use of Cytology, E6/E7 mRNA, and p16INK4a-Ki-67 to Define the Management of Human Papillomavirus (HPV)-Positive Women in Cervical Cancer Screening.
    Gustinucci D, Giorgi Rossi P, Cesarini E, Broccolini M, Bulletti S, Carlani A, D'angelo V, D'amico MR, Di Dato E, Galeazzi P, Malaspina M, Martinelli N, Spita N, Tintori B, Giaimo MD, Passamonti B.
    Am J Clin Pathol; 2016 Jan 23; 145(1):35-45. PubMed ID: 26712869
    [Abstract] [Full Text] [Related]

  • 17. Presence of High-Risk HPV mRNA in Relation to Future High-Grade Lesions among High-Risk HPV DNA Positive Women with Minor Cytological Abnormalities.
    Johansson H, Bjelkenkrantz K, Darlin L, Dilllner J, Forslund O.
    PLoS One; 2015 Jan 23; 10(4):e0124460. PubMed ID: 25893988
    [Abstract] [Full Text] [Related]

  • 18. Human papillomavirus (HPV) E6/E7 mRNA detection in cervical exfoliated cells: a potential triage for HPV-positive women.
    Yao YL, Tian QF, Cheng B, Cheng YF, Ye J, Lu WG.
    J Zhejiang Univ Sci B; 2015 Jan 23; 18(3):256-262. PubMed ID: 28271661
    [Abstract] [Full Text] [Related]

  • 19. Clinical performance of multiplex high-risk e6 mrna expression in comparison with hpv dna subtypes for the identification of women at risk of cervical cancer.
    Ho CM, Pan KY, Chen YY, Huang CY, Chen YL, Chang SF.
    J Med Virol; 2015 Aug 23; 87(8):1404-12. PubMed ID: 25940199
    [Abstract] [Full Text] [Related]

  • 20. HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women.
    Duvlis S, Popovska-Jankovic K, Arsova ZS, Memeti S, Popeska Z, Plaseska-Karanfilska D.
    J Med Virol; 2015 Sep 23; 87(9):1578-86. PubMed ID: 25880030
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.